USA - NASDAQ:TSHA - US8776191061 - Common Stock
Overall TSHA gets a fundamental rating of 2 out of 10. We evaluated TSHA against 536 industry peers in the Biotechnology industry. The financial health of TSHA is average, but there are quite some concerns on its profitability. TSHA does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -27.82% | ||
ROE | -37.28% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.17 | ||
Debt/FCF | N/A | ||
Altman-Z | 6.9 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 12.48 | ||
Quick Ratio | 12.48 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
4.76
-0.12 (-2.46%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 160.35 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 5.22 | ||
P/tB | 5.22 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -27.82% | ||
ROE | -37.28% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.17 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 35.66% | ||
Cap/Sales | 5.1% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 12.48 | ||
Quick Ratio | 12.48 | ||
Altman-Z | 6.9 |